Related references
Note: Only part of the references are listed.Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment
Emanuele Cencini et al.
HEMATOLOGICAL ONCOLOGY (2017)
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
Marco Ruella et al.
CANCER DISCOVERY (2017)
IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
B. Xiu et al.
BLOOD CANCER JOURNAL (2015)
Macrophage Polarization Reflects T Cell Composition of Tumor Microenvironment in Pediatric Classical Hodgkin Lymphoma and Has Impact on Survival
Mario H. M. Barros et al.
PLOS ONE (2015)
Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients
Olivier Morales et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Analysis of biological and technical variability in gene expression assays from formalin-fixed paraffin-embedded classical Hodgkin lymphomas
Gabriela Vera-Lozada et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
Herve Ghesquieres et al.
CYTOKINE (2013)
Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma
Nils Schoof et al.
ONCOLOGIST (2013)
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Mario Henrique M. Barros et al.
PLOS ONE (2013)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Subhra K. Biswas et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Regulation of adaptive immunity; the role of interleukin-10
T. H. Sky Ng et al.
FRONTIERS IN IMMUNOLOGY (2013)
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
D. Azambuja et al.
ANNALS OF ONCOLOGY (2012)
Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection
Mario Henrique M. Barros et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
Olav E. Yri et al.
LEUKEMIA & LYMPHOMA (2012)
Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease
Shankar Subramanian Iyer et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
Peter Kamper et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Macrophages predict treatment outcome in Hodgkin's lymphoma
Christian Steidl et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Disease patterns in pediatric classical Hodgkin lymphoma: a report from a developing area in Brazil
Mario Henrique M. Barros et al.
HEMATOLOGICAL ONCOLOGY (2011)
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
Christian Steidl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production
L. Larsson et al.
GENES AND IMMUNITY (2010)
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
Donatella Aldinucci et al.
JOURNAL OF PATHOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
Alexandar Tzankov et al.
PATHOBIOLOGY (2010)
The regulation of IL-10 production by immune cells
Margarida Saraiva et al.
NATURE REVIEWS IMMUNOLOGY (2010)
c-Maf Regulates IL-10 Expression during Th17 Polarization
Jiangnan Xu et al.
JOURNAL OF IMMUNOLOGY (2009)
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma
Stefan Hohaus et al.
LEUKEMIA RESEARCH (2009)
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma
Roger Rautert et al.
LEUKEMIA & LYMPHOMA (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma
S. Hohaus et al.
ANNALS OF ONCOLOGY (2007)
The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages
SJ Cao et al.
JOURNAL OF IMMUNOLOGY (2005)
Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level
FAS Kurreeman et al.
HUMAN MOLECULAR GENETICS (2004)
Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used
M Mörmann et al.
GENES AND IMMUNITY (2004)
Are cytokine gene polymorphisms related to in vitro cytokine production profiles?
MC Warlé et al.
LIVER TRANSPLANTATION (2003)
Differential regulation of interleukin-10 production by genetic and environmental factors -: a twin study
E Reuss et al.
GENES AND IMMUNITY (2002)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism
ME Helminen et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene
D Kube et al.
GENES AND IMMUNITY (2001)
Are differences in interleukin 10 production associated with joint damage?
TWJ Huizinga et al.
RHEUMATOLOGY (2000)
Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels - Clinical significance of interleukin-l0 serum levels for Hodgkin's disease
H Bohlen et al.
ANNALS OF HEMATOLOGY (2000)
Elevated pretreatment serum levels of IL-10 are associated with a poor prognosis in Hodgkin's disease, the Milan Cancer Institute Experience
S Viviani et al.
MEDICAL ONCOLOGY (2000)
Share Paper
